Integration of artificial intelligence and precision oncology in Latin America

Next-generation medicine encompasses different concepts related to healthcare models and technological developments. In Latin America and the Caribbean, healthcare systems are quite different between countries, and cancer control is known to be insufficient and inefficient considering socioeconomically discrepancies. Despite advancements in knowledge about the biology of different oncological diseases, the disease remains a challenge in terms of diagnosis, treatment, and prognosis for clinicians and researchers. With the development of molecular biology, better diagnosis methods, and therapeutic tools in the last years, artificial intelligence (AI) has become important, because it could improve different clinical scenarios: predicting clinically relevant parameters, cancer diagnosis, cancer research, and accelerating the growth of personalized medicine. The incorporation of AI represents an important challenge in terms of diagnosis, treatment, and prognosis for clinicians and researchers in cancer care. Therefore, some studies about AI in Latin America and the Caribbean are being conducted with the aim to improve the performance of AI in those countries. This review introduces AI in cancer care in Latin America and the Caribbean, and the advantages and promising results that it has shown in this socio-demographic context.

• Autores: Sussman, Liliana; García-Robledo, Juan Esteban; Ordóñez-Reyes, Camila; Forero, Yency; Mosquera, Andrés F.; Ruíz-Patiño, Alejandro; Chamorro, Diego F.
• Tipo de recurso: Article of journal
• Fecha de publicación: 2022
• Institución: Universidad El Bosque
• Repositorio: Repositorio U. El Bosque
• Idioma: eng
• OAI Identifier: oai:repositorio.unbosque.edu.co:20.500.12495/11152
• Acceso en línea: http://hdl.handle.net/20.500.12495/11152; https://doi.org/10.3389/fmedt.2022.1007822
• Palabra clave: Inteligencia artificial; Latinoamérica; Oncología; Oncología de precisión; Tecnología; Artificial intelligence; Latin America; Oncology; Precision oncology; Technology
• Rights: openAccess
• License: Atribución 4.0 Internacional